Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Ikarian Capital, LLC
Form 13F · Q2 2026

Ikarian Capital, LLC

CIK 1778253Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$928M
Reported book value
156
Positions
12
Quarters on record
Top 50
Positions

Ikarian Capital, LLC — holdings

Top 50 positions of 156, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1ABIVAX SA Abivax Sa328,635+470.2%$43M4.7%
2KOD Kodiak Sciences Inc1.1M−16.3%$41M4.4%
3ALMS Alumis Inc870,548−28.3%$24M2.6%
4PRAX Praxis Precision Medicines I72,842+1.8%$24M2.6%
5PCVX Vaxcyte Inc388,682−9.3%$23M2.4%
6ANIP Ani Pharmaceuticals Inc272,085+85.0%$23M2.4%
7CLDX Celldex Therapeutics Inc New478,500+3.7%$18M1.9%
8RCUS Arcus Biosciences Inc504,559—$16M1.7%
9RLMD Relmada Therapeutics Inc2.1M−20.1%$15M1.6%
10CAPR Capricor Therapeutics Inc604,215+14.4%$15M1.6%
11COGT Cogent Biosciences Inc370,084—$14M1.5%
12VERA Vera Therapeutics Inc310,000+55.0%$13M1.4%
13CTNM Contineum Therapeutics Inc807,874+0.0%$13M1.4%
14TENX Tenax Therapeutics Inc787,600−22.6%$11M1.2%
15CCCC C4 Therapeutics Inc2.4M—$11M1.2%
16MAZE Maze Therapeutics Inc378,999+0.0%$11M1.2%
17BHVN Biohaven Ltd748,181+81.4%$11M1.2%
18CNTB Connect Biopharma Hldgs Ltd4.5M−15.8%$11M1.2%
19ANRO Alto Neuroscience Inc407,338−20.9%$11M1.2%
20PHVS Pharvaris N V308,856−36.6%$11M1.2%
21JBIO Jade Biosciences Inc427,349−16.6%$9M1.0%
22DMRA Damora Therapeutics Inc335,710+0.0%$9M0.9%
23VRDN Viridian Therapeutics Inc425,000—$8M0.8%
24PTHS Pelthos Therapeutics Inc256,598+0.0%$7M0.8%
25ZURA Zura Bio Ltd1.2M+2.1%$7M0.8%
26TECX Tectonic Therapeutic Inc205,837+30.7%$7M0.8%
27SPRB Spruce Biosciences Inc121,356+0.0%$7M0.7%
28HIMS Hims & Hers Health Inc188,381—$7M0.7%
29ELVN Enliven Therapeutics Inc126,541—$6M0.7%
30PROQR THRAPEUTICS N V Proqr Thrapeutics N V3.4M+129.6%$6M0.7%
31DRUG Bright Minds Biosciences Inc88,951−46.6%$6M0.7%
32OVID Ovid Therapeutics Inc2.3M−21.6%$6M0.7%
33OCGN Ocugen Inc4.0M+0.0%$6M0.7%
34ACOG Alpha Cognition Inc836,259−20.8%$6M0.7%
35HROW Harrow Inc135,775−75.0%$6M0.6%
36KZIA Kazia Therapeutics Ltd396,201—$6M0.6%
37RARE Ultragenyx Pharmaceutical In165,617−65.7%$6M0.6%
38QTTB Q32 Bio Inc430,000—$5M0.6%
39EPRX Eupraxia Pharmaceuticals Inc809,741−33.3%$5M0.6%
40BIOA Bioage Labs Inc200,000—$5M0.5%
41RZLT Rezolute Inc935,012+5574.0%$5M0.5%
42OLEMA PHARMACEUTICALS INC Olema Pharmaceuticals Inc383,281−35.9%$5M0.5%
43MNPR Monopar Therapeutics Inc47,861—$4M0.5%
44BBIO Bridgebio Pharma Inc57,417−64.1%$4M0.5%
45IVA Inventiva Sa1.1M−21.0%$4M0.4%
46ABSI Absci Corporation353,772—$4M0.4%
47ALEC Alector Inc2.0M−4.8%$4M0.4%
48CLYM Climb Bio Inc300,000—$4M0.4%
49FULC Fulcrum Therapeutics Inc1.0M+0.0%$4M0.4%
50CRDL Cardiol Therapeutics Inc3.3M+22.0%$4M0.4%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.